The crude extract demonstrated significant antioxidant activity, especially in the ABTS assay (IC<sub>50</sub> = 50.18 μg/mL), considerable cytotoxicity against MCF-7 breast cancer cells, diminished efficacy against the drug-resistant MCF-7/Adr cell line, and preferential inhibition of butyrylcholinesterase compared to acetylcholinesterase. The gene discussed is ACHE; the disease is breast carcinoma.